Bio-Rad Laboratories (BIO-B) Shares Outstanding (Weighted Average) (2009 - 2026)

Bio-Rad Laboratories (BIO-B) has 18 years of Shares Outstanding (Weighted Average) data on file, last reported at $27.0 million in Q1 2026.

• Quarterly Shares Outstanding (Weighted Average) fell 3.52% year-over-year to $27.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $27.0 million (down 3.52% YoY) and the FY2025 annual result came in at $27.3 million, down 3.37% from the prior year.
• Shares Outstanding (Weighted Average) eased to $27.0 million in Q1 2026 per BIO-B's latest filing, from $27.3 million in the prior quarter.
• Across five years, Shares Outstanding (Weighted Average) topped out at $29.9 million in Q1 2022 and bottomed at $26.9 million in Q3 2025.
• The 5-year median for Shares Outstanding (Weighted Average) is $28.5 million (2024), against an average of $28.6 million.
• The widest annual swing landed in 2022, when Shares Outstanding (Weighted Average) gained 0.37%; it then fell 4.82% in 2025.
• Tracing BIO-B's Shares Outstanding (Weighted Average) over 5 years: stood at $29.8 million in 2022, then declined by 1.93% to $29.2 million in 2023, then declined by 3.41% to $28.2 million in 2024, then slipped by 3.37% to $27.3 million in 2025, then slipped by 1.12% to $27.0 million in 2026.
• Per Business Quant, the three latest BIO-B Shares Outstanding (Weighted Average) figures stand at $27.0 million (Q1 2026), $27.3 million (Q4 2025), and $26.9 million (Q3 2025).

Peer Comparison